ELLICOTT CITY, Md., Aug. 29, 2017 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) today announced the finalists for the 2017 SCRS Eagle Award™. The finalists were selected from companies nominated by SCRS members. Qualifying nominees were in the 75th percentile or higher of the total nominations submitted. Voting is now open to all clinical research site professionals, regardless of their membership with SCRS. The opportunity to vote closes September 22nd. Click here to vote.
Congratulations to the 2017 Sponsor finalists: AbbVie, AstraZeneca, Eli Lilly & Co., GlaxoSmithKline, Merck, Novo Nordisk, Purdue Pharma, and Sanofi.
Congratulations to the 2017 CRO finalists: ICON, INC Research/inVentiv Health, PRA Health Sciences, and QuintilesIMS.
"SCRS member sites are eager to recognize the companies that work collaboratively with sites and create an environment where everyone succeeds," said Christine Pierre, president of SCRS. Congratulations to each Eagle Award finalist, and I look forward to announcing the Sponsor and CRO Eagle Award honorees who will be celebrated during the Eagle Award Gala at the SCRS Global Site Solutions Summit."
SCRS is a global trade organization founded in 2012 which represents almost 9,000 research sites in over 45 countries. SCRS' mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.
SOURCE Society for Clinical Research Sites